Vaxart, Inc. (VXRT)
0.5747
-0.02
(-2.58%)
USD |
OTCM |
Feb 11, 15:56
Vaxart EPS Diluted (Quarterly) : -0.0356 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bionano Genomics, Inc. | -1.593 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.141M |
| Revenue (Quarterly) | 72.41M |
| Total Expenses (Quarterly) | 80.55M |
| Enterprise Value | 131.78M |
| Gross Profit Margin (Quarterly) | 97.13% |
| Profit Margin (Quarterly) | -11.24% |
| Earnings Yield | -38.66% |
| Normalized Earnings Yield | -38.66 |